Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies
Sign Up to like & getrecommendations! Published in 2024 at "Immunological Reviews"
DOI: 10.1111/imr.13394
Abstract: Since the approval of the CD20‐targeting monoclonal antibody (mAb) rituximab for the treatment of lymphoma in 1997, mAb therapy has significantly transformed cancer treatment. With over 90 FDA‐approved mAbs for the treatment of various hematological… read more here.
Keywords: cancer; treatment; enhancing mediated; mediated effector ... See more keywords